Belgium Medical Inc.:Reports Great Success at Porter Adventist Hospital Healthcare Conference & CARDEO Conference, Denver, Colorado September 17-19, 2004

VANCOUVER, BRITISH COLUMBIA, Oct 21, 2004 (CCNMatthews via COMTEX) --

Meridian Co., Ltd. ("Meridian") (OTC BB: MRDAF), is pleased to announce that its subsidiary, Belgium Medical Inc. ("MMI" or "the Company") experienced continuing success the Porter Adventist Hospital Healthcare Conference & CARDEO Conference in Denver, Colorado from September 17 - 19, 2004.

Hundreds of Physicians, Cardiologists and Allied Healthcare professionals from across the United States were in attendance and were introduced to the Digital Pulse Analyzer ("DPA"). The prevention-minded physicians were very receptive to the FDA approved cardiovascular diagnostic device. The comments received were all positive from the ease of use, the amount of information obtained, and cost-effectiveness.

MMI was also invited to provide testing to the Consumer Health Expo which drew consumers of all ages and backgrounds. MMI provided this testing at no charge to consumers as a way to promote preventative health and provide these consumers with an indication of their arterial health at present. One of MMI's United States distributors, Cardiograde, was also in attendance to assist with the tremendous interest in its technology.

"It was an honor to be included in the consumer cardiac testing forum at the Conference. It gave us an opportunity to test approximately 500 citizens of the Denver area. This was a collaborative effort to educate the public on the nation's number one killer, cardiovascular disease, and to discuss the importance of early diagnosis and proactive choices", stated Debbie Williams, President of MMI.

More About CARDEO: CARDEO'S Mission: Prevention before Intervention(TM)

CARDEO'S mission is to empower consumers, primary care physicians, healthcare providers, nutriceutical and pharmaceutical companies to launch a collaborative commitment to reduce and ultimately eliminate the nation's number one killer - heart disease. CARDEO strives to eradicate heart disease by increasing public awareness of heart attack risk factors, and encouraging broad public access to heart risk testing, early diagnosis, and preventative measures.

More About: Digital Pulse Analyzer ("DPA")

The "DPA" accurately measures the elasticity of small and large arteries and provides health care practitioners with critical information regarding arterial aging. This FDA approved device is inexpensive, non-invasive, and can provide results in minutes. Accumulating evidence suggests that abnormalities in the pulsatile characteristics of arteries occur early in the disease process associated with increased cardiovascular risk, and can be favorably modified by therapeutic interventions.

The Company feels that use of the "DPA" can help caregivers reduce cardiovascular disease in their patient populations through early detection and prevention, and ultimately assist to decrease the associated financial costs placed on the health care industry. Cardiovascular disease is the #1 killer in the United States with an estimated economic cost of approximately $298 billion.

More About: Meridian

Meridian is an established leader in the research/development, manufacturing, and sales of integrative medical diagnostic equipment. The company sells its products and equipment to a wide array of customers in the global health care industry. The company presently holds a total of 18 worldwide patents on its technology, and has received FDA, as well as other international regulatory approvals for many of its products.

Meridian is committed to the ongoing global research and advancement of integrative medical products that contribute to the better health of humanity.

Website (Korean): www.meridian.co.kr

Website (North American): meridianmedical.ca

Lexington Communications
Larry Kristof
(877) 899-4550
Email: 
[email protected]

NEWS RELEASE TRANSMITTED BY CCNMatthews